HNF4A and hepatocellular carcinoma: Enhanced activities from preS1, preS2/S, core promoter, and Enh- II as a result of binding of liver enriched TFs, including HNF1α, HNF3α and HNF4α were observed using hepatoma cells [9,10,11].